Helicobacter pylori Infection and Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

被引:21
|
作者
Heydari, Keyvan [1 ,2 ]
Yousefi, Mohammad [3 ]
Alizadeh-Navaei, Reza [2 ]
Lotfi, Parisa [1 ]
Sheydaee, Fateme [3 ]
Raei, Maedeh [4 ]
Vahdatinia, Alireza [1 ]
Hessami, Amirhossein [1 ]
Rafati, Sajjad [1 ]
Moosazadeh, Mahmood [2 ]
Ghasemian, Roya [5 ]
Salehi, Fatemeh [6 ]
Massoudi, Haleh [7 ]
Ghaffari-Saravi, Fatemeh [8 ]
Rismantab, Sahar [7 ]
机构
[1] Mazandaran Univ Med Sci, Fac Med, Student Res Comm, Sari, Iran
[2] Mazandaran Univ Med Sci, Gastrointestinal Canc Res Ctr, Noncommunicable Dis Inst, Sari, Iran
[3] Semnan Univ Med Sci, Dept Med, Fac Med, Semnan, Iran
[4] Islamic Azad Univ, Fac Med, Sari Branch, Sari, Iran
[5] Mazandaran Univ Med Sci, Antimicrobial Resistance Res Ctr, Dept Infect Dis, Sari, Iran
[6] Islamic Azad Univ, Dept Pathol, Sari Branch, Fac Med, Sari, Iran
[7] Mazandaran Univ Med Sci, Ramsar Campus, Ramsar, Iran
[8] Mazandaran Univ Med Sci, Tradit & Complementary Med Res Ctr, Addict Inst, Sari, Iran
来源
TURKISH JOURNAL OF GASTROENTEROLOGY | 2022年 / 33卷 / 03期
关键词
Fatty liver; Helicobacter; meta-analysis; steatohepatitis; NONALCOHOLIC STEATOHEPATITIS; HEPATIC-FIBROSIS; PREVALENCE; NAFLD;
D O I
10.5152/tjg.2022.21467
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Since numerous studies have stated that there may be a relationship between Helicobacter pylon infection and nonalcoholic fatty liver disease and because of the high prevalence of both conditions worldwide, this study investigated the risk of non-alcoholic fatty liver in patients liver disease in patients infected with H. pylon. Following a systematic review of PubMed, Scopus, Web of Science and Embase, and a search in Google Scholar using MeSH terms such as H. pylon and non-alcoholic fatty liver disease, the relevant papers up to November 2020 were reviewed. All cohort, case-control, and cross-sectional studies that examined the risk of developing non-alcoholic fatty liver disease in patients infected with H. pylori entered this study. A meta-analysis was conducted in STATA 11. This systematic review examined 22 papers with 117 117 participants (33 711 patients infected with H pylori and 83 406 participants as control) and 20 studies were subjected to meta-analysis The results indicated a 22% to 27% increase in the risk of developing non-alcoholic fatty liver disease in patients infected with H. pylori (crude odds ratio: 1.27, 95% CI 1.17-1.33; and adjusted odds ratio: 1.22, 95% CI: 1.09-1.35). According to the subgroup analysis, the study region, sample size, and the method of diagnosing H. pylori were the factors contributing to the high heterogeneity. The meta-analysis revealed the increased risk of developing non-alcoholic fatty liver disease in patients infected with H. pylon TI is indicates that H. pylori is a serious risk factor in patients susceptible to NAFLD.
引用
收藏
页码:171 / 181
页数:11
相关论文
共 50 条
  • [1] Association between Helicobacter pylori infection and non-alcoholic fatty liver disease for Asian and non-Asian population: A systematic review and meta-analysis
    Ma, Zhiyuan
    Chu, Xiajing
    Yan, Xiang
    Wang, Wenjin
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [2] Non-alcoholic fatty liver disease in pregnancy: A systematic review with meta-analysis
    El Jamaly, H.
    Weltman, M.
    Eslick, G. D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 63 - 63
  • [3] Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis
    Li, Yan
    Liu, Lei
    Wang, Bin
    Wang, Jun
    Chen, Dongfeng
    BIOMEDICAL REPORTS, 2013, 1 (01) : 57 - 64
  • [4] Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis
    Keating, Shelley E.
    Hackett, Daniel A.
    George, Jacob
    Johnson, Nathan A.
    JOURNAL OF HEPATOLOGY, 2012, 57 (01) : 157 - 166
  • [5] Systematic Review and Meta-Analysis of the Association Between H. pylori and Non-Alcoholic Fatty Liver Disease
    Kamal, Faisal
    Khan, Muhammad Ali
    Shrestha, Shreesh
    Tariq, Raseen
    Reddy, Yala
    Marella, Hemnishil K.
    Howden, Colin W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1603 - S1604
  • [6] Helicobacter pylori and non-alcoholic fatty liver disease
    Buzas, Gyorgy M.
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2020, 66 (03) : 267 - 279
  • [7] The Prevalence and Association Between Non-Alcoholic Fatty Pancreas Disease and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
    Randich, Karla Hernandez
    Chaponan-Lavalle, Andres
    Norwood, Dalton A.
    Montalvan-Sanchez, Eleazar E.
    Izquierdo-Veraza, Diego
    Riva-Moscoso, Adrian
    Sevilla-Acosta, Eduardo
    Calderon, Eduardo
    Ramirez-Rojas, Mirian
    Calderon, Gerardo
    Beas, Renato
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S49 - S50
  • [8] Statins' efficacy in non-alcoholic fatty liver disease: A systematic review and meta-analysis
    Boutari, Chrysoula
    Pappas, Panagiotis D.
    Anastasilakis, Dimitrios
    Mantzoros, Christos S.
    CLINICAL NUTRITION, 2022, 41 (10) : 2195 - 2206
  • [9] Efficacy of orlistat in non-alcoholic fatty liver disease: A systematic review and meta-analysis
    Wang, Hu
    Wang, Li
    Cheng, Yujia
    Xia, Zhiqing
    Liao, Yifeng
    Cao, Jiang
    BIOMEDICAL REPORTS, 2018, 9 (01) : 90 - 96
  • [10] Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis
    Polyzos, Stergios A.
    Aronis, Konstantinos N.
    Kountouras, Jannis
    Raptis, Dimitrios D.
    Vasiloglou, Maria F.
    Mantzoros, Christos S.
    DIABETOLOGIA, 2016, 59 (01) : 30 - 43